MBP
Click for more information
3.23% 3.0¢ metabolic pharmaceuticals limited

...looks like this would be one of your competitors.Not really....

  1. jevalent
    5,261 Posts.
    lightbulb Created with Sketch. 244
    clock Created with Sketch.
    14/06/07
    03:05
    Post #: 2535384
    ...looks like this would be one of your competitors.

    Not really. It looks to me like this product is a treatment for nociceptive pain, not neuropathic pain like ACV1.

    Two different indications, two different markets.
    MBP Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TRP Tissue Repairs soars nearly 32% on TGA approval for wound healing gel
right-arrow Created with Sketch.
PEC Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
HRZ Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision
right-arrow Created with Sketch.
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.